House Appropriations Committee Passes 2016 Agriculture Appropriations Bill!
Yesterday, the House Appropriations Committee approved the fiscal year 2016 Agriculture Appropriations bill on a voice vote. The proposed legislation funds important agricultural and food programs and services, including food and medical product safety, animal and plant health programs, rural development and farm services, marketplace oversight, and nutrition programs.
IACP is extremely pleased to announce that several of the sections affecting compounding upon which we have lobbied very hard and also were part of our IACP Compounders on Capitol Hill (CCH) "Ask" documents were included in the approved Appropriations bill.
Please click here to view the full committee bill.
Please click here to review the specific parts of the bill affecting compounding.
A huge thank you to all of our members who have advocated along with the Academy to ensure that this language was included in the Appropriations bill. Your efforts have made a huge difference!
Please email IACP at firstname.lastname@example.org if you have any questions.
IACP Membership Survey: Help Shape Your Academy's Future!
Please complete by Friday, July 24th.
Last summer, the IACP leadership developed a multi-year strategic plan to guide the Academy in tackling many of the opportunities and challenges facing the compounding pharmacy community. In addition to expanding our educational programs, publications, and our legislative efforts at the federal and state level, this plan directly guides our organization as it enters its 25th year.
To see how we're doing and where YOU want us to go, we've created this brief member survey. It will take less than five minutes of your time but that investment will bring enormous return to IACP.
The survey will be available until Friday, July 24.
Please click here or on the graphic above to take the survey.
IACP Board Elections: Call for Nominations
IACP’s 2015 Call for Nominations and the 2015 Election Cycle for the new 2016 Board members is now open! The Bylaws of IACP set forth an open election process with nominations for candidates accepted directly from the membership.
Interested candidates may be nominated or may be self-nominated to the IACP Nominating Committee chaired by IACP Immediate Past President Pat Stephens, PharmD. The IACP Board of Directors receives the Nominating Committee report at its October Board Meeting, approves the slate of candidates, and then all qualified IACP members are able to participate in the election process held each November. This year, there are four Board of Directors’ seats for which candidates are sought as well nominees for the position of IACP Vice President.
Please click here to read more.
July 20th Deadline Approaching - Comments Due for FDA MOU
The Food and Drug Administration (FDA) extended the comment period in the notice of availability that originally appeared in the Federal Register of February 19, 2015 to July 20, 2015. The Agency extended the comment period both for the draft standard Memorandum of Understanding (MOU) and for information collection issues under the PRA for 30 days, until July 20, 2015.
Please click here for FDA's website to view information and comment.
Please click here to view IACP's draft comments to FDA. We are still making modifications and the link to the document is marked as a draft.
The U.S. Food & Drug Administration (FDA) established a public docket to receive information, recommendations, and comments on matters related to the Agency’s regulation of compounding of human drug products under sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act (FD&C Act).
This docket is intended for general comments related to human drug compounding that are not specific to documents or issues that are the subject of other dockets. So, while IACP and compounders can submit comments on the draft guidance documents that are directly related to repackaging, adverse event reporting, and the Memorandum of Understanding there has been no place where physicians, patients, pharmacists and others can voice our concerns about office-use.
If office-use is important to your practice or your prescriber clientele, this public docket is the perfect place to file your comments about how the FDA is ignoring Congressional intent and disregarding state laws and regulations permitting office-use.
IACP has filed comments on the FDA Guidance Document with the Agency. Please click the below links to view IACP's comments.
FDA's "Repackaging of Certain Human Drug Products by Pharmacies and Outsourcing Facilities"
"Adverse Event Reporting for Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act"
"Repackaging of Biologics"
Letter from Congress
Click here to view a Congressional letter regarding the repackaging of biologics.
FDA Public Docket
IACP Members! Click here to access the FDA Public Docket, which includes comment submission instructions.
Make your voice heard! Let the FDA know of your concerns on the recent compounding implementation plan.
IACP Summary on FDA Four Draft Guidance Document
Please click here to view.
NASPA-Convened Workgroup Develops Collaborative Practice Authority Recommendations
The Collaborative Practice Workgroup, convened by the National Alliance of State Pharmacy Associations (NASPA), has developed recommendations for the elements of pharmacist collaborative practice authority that should appropriately be defined under state law or regulation and which are best left to be determined between pharmacists and other practitioners when developing their specific collaborative practice arrangement.
Workgroup participants, pharmacists from a variety of settings who were appointed by the NASPA Executive Committee and the national pharmacy associations, considered the existing landscape of state laws and regulations, patient access, and pharmacist education and training in compiling their recommendations.
NASPA CEO, Becky Snead, on the importance of this work: “It is critical to have a national set of collaborative practice authority recommendations for state policy makers that are based on the best interests of patients and the education and training of pharmacists. This work builds on and supports the policy considerations from the National Governors Association in their 2015 paper, The Expanding Role of Pharmacists in a Transformed Health Care System.”
Please click here to read the report.
Corporate Partner Topi-CLICK Donates $25,000 to IACP's One Fund Fundraising Campaign!
At Compounders on Capitol Hill this year, IACP President Dale Coker, RPh, FIACP, issued a personal challenge to our membership and Corporate Sponsors to donate to IACP’s One Fund.
"IACP has a clear goal to be proactive rather than a reactive organization," says Coker. "To accomplish this, it requires capital. We need to replenish our reserves used in defending compounding in the wake of the NECC crisis of 2012. We need to build our war chest for the next coalition that will need to be formed. There are many issues on the horizon, with the Veterinary Compounding Compliance Policy Guide, third party reimbursement and third party credentialing to name a few. We need funding available to act NOW, not after a crisis sets in.
Corporate Partner Topi-CLICK heard our call and donated $25,000 to One Fund. Their generosity will help us reach our goal of $2 million dollars by the end of 2016.
During CCH, we raised an additional $52,000 and $15,000 in future donations from members for a total of $87,000. To date we are at $413,000 which is about 21 percent of our goal with a quarter of our timeline already gone.
Thank you, Topi-CLICK, for your ongoing generosity to the Academy. We greatly appreciated your support. On behalf of our Board and Members, thank you.
IACP Members and Corporate Partners: Please join us in our efforts to Protect, Preserve and Advance Pharmacy Compounding by making a donation to IACP’s One Fund fundraising campaign. Please click here to donate online, or click here to access a One Fund donation form.
IACP Member News
Kevin Borg Named 2015 Next-Generation Pharmacist Finalist
IACP Board Member and Peoria, Ariz. business owner, Pharmacist Kevin Borg, PharmD, FIACP, has been named a finalist for the nationally recognized 2015 Next-Generation Pharmacist awards for the entrepreneur category.
The award honor pharmacists, technicians, student pharmacists and industry advocates who are defining the future of the industry. Please click here for more information.
Eddie Glover Installed as President-elect of the Arkansas Pharmacists Association
IACP Member and Former Board Member Eddie Glover, P.D., of Conway, Ark., has been installed as President-Elect of the Arkansas Pharmacists Association (APA) at its 133rd Annual Convention held June 11-13 at the Little Rock Embassy Suites.
He has served for the past year as APA Vice President. Before that, he served as APA Area 3 Representative and District 1 President. He is a member of the National Community Pharmacists Association (NCPA) and served on its Multi-Location Committee. He is also a member of the board of directors for Pharmacy Partners of America. Glover was named NCPA “Pharmacist of the Year” in 2012. Please click here to read more.